Brief: Cannabics Pharmaceuticals & Cannomed Collaborate To Develop Cannabis Strains Targeting Cancers
10/06/2020 15:47
June 10 (Reuters) - Cannabics Pharmaceuticals Inc CNBX.PK :
* CANNABICS PHARMACEUTICALS AND CANNOMED COLLABORATE TO
DEVELOP
CANNABIS STRAINS TARGETING CANCERS
Source text for Eikon: urn:newsml:reuters.com:*:nPn7ZbkTya
Further company coverage: CNBX.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CNBX Pharmaceuticals
See all newsBrief: Cannabics Pharmaceuticals Appoints Second Independent Board Member
Brief: Cannabics Prepares To Submit FDA With Pre-IND Meeting Request For Proprietary Colon Cancer Drug Candidate
Brief: Cannabics Pharmaceuticals Appoints Dr. Dana Ben-Ami Shor To Its Scientific Board Of Advisors
Brief: Cannabics Pharmaceuticals Initiates Entry For Its Cannabinoid Diagnostic Platform Into European Markets
Brief: Cannabics Pharmaceuticals & Cannomed Collaborate To Develop Cannabis Strains Targeting Cancers